Effect of low-dose atropine on young premyopic and low-myopic children: atropine treatment of myopia (ATOM3) - a randomised control trial.

چکیده

To evaluate the effectiveness of atropine 0.01% in young premyopic and low-myopic children. Children (5-9 years old) with premyopia (spherical equivalent refraction, SER+1.00 to -0.49D, n 156) or low myopia (SER -0.50 to -1.50D, n 52), with at least 1 parent with myopia <-3.00D, were randomised to…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط